XELODA

This brand name is authorized in United States. It is also authorized in Albania, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Singapore, South Africa, Spain, Tunisia.

Active ingredients

The drug XELODA contains one active pharmaceutical ingredient (API):

1	Capecitabine UNII 6804DJ8Z9U - CAPECITABINE
	Capecitabine is a non-cytotoxic fluoropyrimidine carbamate, which functions as an orally administered precursor of the cytotoxic moiety 5-fluorouracil (5-FU). There is evidence that the metabolism of 5-FU in the anabolic pathway blocks the methylation reaction of deoxyuridylic acid to thymidylic acid, thereby interfering with the synthesis of deoxyribonucleic acid (DNA). The incorporation of 5-FU also leads to inhibition of RNA and protein synthesis.
	Read more about Capecitabine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Xeloda 150mg and 500mg Film-coated Tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01BC06	Capecitabine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	578/41
BR	Câmara de Regulação do Mercado de Medicamentos	529206703112315, 529206704119313
CA	Health Products and Food Branch	02238453, 02238454
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00410399, 00410407, 01163661, 05385358, 05516079, 06568687, 06797672, 06849073, 10917538, 12367131, 15612513
EE	Ravimiamet	1013308, 1013319
ES	Centro de información online de medicamentos de la AEMPS	00163002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	397752
FR	Base de données publique des médicaments	65918903, 69771849
HK	Department of Health Drug Office	46233, 46234
IT	Agenzia del Farmaco	035219017, 035219029
JP	医薬品医療機器総合機構	4223005F1022
LT	Valstybinė vaistų kontrolės tarnyba	1003995, 1003996
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	522M98
NL	Z-Index G-Standaard, PRK	59358, 59366
PL	Rejestru Produktów Leczniczych	100103613, 100103620
SG	Health Sciences Authority	10677P, 10678P
TN	Direction de la Pharmacie et du Médicament	6993181H
US	FDA, National Drug Code	0004-1100, 0004-1101
ZA	Health Products Regulatory Authority	33/26/0198, 33/26/0199